Lexaria Bioscience Corp Stock Gross Profit
Lexaria Bioscience Corp fundamentals help investors to digest information that contributes to Lexaria Bioscience's financial success or failures. It also enables traders to predict the movement of Lexaria OTC Stock. The fundamental analysis module provides a way to measure Lexaria Bioscience's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Lexaria Bioscience otc stock.
Lexaria |
Lexaria Bioscience Corp OTC Stock Gross Profit Analysis
Lexaria Bioscience's Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Current Lexaria Bioscience Gross Profit | 276.93 K |
Most of Lexaria Bioscience's fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Lexaria Bioscience Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
CompetitionAccording to the company disclosure, Lexaria Bioscience Corp reported 276.93 K of gross profit. This is 100.0% lower than that of the Consumer Defensive sector and 99.98% lower than that of the Packaged Foods industry. The gross profit for all United States stocks is 100.0% higher than that of the company.
Lexaria Gross Profit Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Lexaria Bioscience's direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Lexaria Bioscience could also be used in its relative valuation, which is a method of valuing Lexaria Bioscience by comparing valuation metrics of similar companies.Lexaria Bioscience is currently under evaluation in gross profit category among related companies.
Lexaria Fundamentals
| Return On Equity | -164.27 | |||
| Return On Asset | -87.72 | |||
| Current Valuation | 21.27 M | |||
| Shares Outstanding | 89.59 M | |||
| Shares Owned By Insiders | 0.60 % | |||
| Shares Owned By Institutions | 0.11 % | |||
| Price To Earning | (13.00) X | |||
| Price To Book | 8.99 X | |||
| Price To Sales | 48.33 X | |||
| Revenue | 384.54 K | |||
| Gross Profit | 276.93 K | |||
| EBITDA | (3.75 M) | |||
| Net Income | (3.93 M) | |||
| Cash And Equivalents | 1.31 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 156.1 K | |||
| Debt To Equity | 0.06 % | |||
| Current Ratio | 8.52 X | |||
| Book Value Per Share | 0.03 X | |||
| Cash Flow From Operations | (2.66 M) | |||
| Earnings Per Share | (0.05) X | |||
| Beta | 2.12 | |||
| Market Capitalization | 18.58 M | |||
| Total Asset | 331 K | |||
| Retained Earnings | (10.99 M) | |||
| Working Capital | (53 K) | |||
| Current Asset | 279 K | |||
| Current Liabilities | 332 K | |||
| Z Score | -10.1 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Lexaria Bioscience in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Lexaria Bioscience's short interest history, or implied volatility extrapolated from Lexaria Bioscience options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Consideration for investing in Lexaria OTC Stock
If you are still planning to invest in Lexaria Bioscience Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Lexaria Bioscience's history and understand the potential risks before investing.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |